ELVN
Enliven Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +1.4% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | +12 | 36.49M | $1.84B | +15 | −3 |
| Q1 2026 | 71 | +9 | 24.13M | $927.49M | +16 | −7 |
| Q4 2025 | 62 | -3 | 26.77M | $412.32M | — | −3 |
| Q3 2025 | 17 | 0 | 20.16M | $412.75M | — | — |
| Q2 2025 | 14 | +1 | 19.32M | $387.50M | +1 | — |
| Q1 2025 | 10 | +1 | 3.57M | $70.26M | +2 | −1 |
| Q4 2024 | 9 | 0 | 4.15M | $93.48M | — | — |
| Q3 2024 | 8 | +1 | 3.55M | $90.68M | +1 | — |
| Q2 2024 | 7 | — | 4.08M | $95.46M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 7.13M | -5.7% | $145.93M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 7.13M | -5.7% | $145.93M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 7.13M | -5.7% | $145.93M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 3.52M | +18.6% | $72.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (pasivo) | 2.55M | +5.9% | $52.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 2.55M | +5.9% | $52.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasivo) | 2.55M | +5.9% | $52.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasivo) | 2.55M | +5.9% | $52.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasivo) | 2.55M | +5.9% | $52.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 1.16M | -21.1% | $23.76M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Geode Capital Management ✦ (pasivo) | 1.09M | +22.9% | $22.21M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Geode Capital Management ✦ (pasivo) | 1.09M | +22.9% | $22.21M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Point72 Asset Management ✦ | 1.04M | -23.1% | $21.30M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (pasivo) | 965.14K | +18.2% | $19.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | Duquesne Family Office ✦ | 947.40K | +104.6% | $19.39M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 26 | Millennium Management ✦ | 381.40K | +19.8% | $7.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Marshall Wace ✦ | 340.48K | +2.1% | $6.97M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 28 | Marshall Wace ✦ | 340.48K | +2.1% | $6.97M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 29 | Marshall Wace ✦ | 340.48K | +2.1% | $6.97M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Goldman Sachs Group ✦ | 262.27K | — | $5.37M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Goldman Sachs Group ✦ | 262.27K | — | $5.37M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 258.38K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 258.38K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 258.38K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 258.38K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Morgan Stanley ✦ | 258.38K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Morgan Stanley ✦ | 258.38K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 231.30K | -56.2% | $4.74M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 39 | T. Rowe Price ✦ | 231.30K | -56.2% | $4.74M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 40 | Wellington Management ✦ | 108.56K | +15.5% | $2.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 41 | Wellington Management ✦ | 108.56K | +15.5% | $2.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | Wellington Management ✦ | 108.56K | +15.5% | $2.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 43 | Adage Capital Partners ✦ | 73.00K | -24.0% | $1.49M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 44 | Renaissance Technologies ✦ | 59.00K | +146.9% | $1.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 49.64K | — | $1.02M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 49.64K | — | $1.02M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 49.64K | — | $1.02M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 49.64K | — | $1.02M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 49.64K | — | $1.02M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 49.64K | — | $1.02M | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 2.40K acciones, $94,276 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 3.90K acc. · $227,650
Officer · 1.10K acc. · $65,281
Officer · 4.63K acc. · $270,168
Officer · 1.39K acc. · $82,383
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología
9.5% de clase · Ver presentación original ante la SEC ↗
10.9% de clase · Ver presentación original ante la SEC ↗